Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2017 Filed Dec 19, 2017 21:44 UTC |
LIVERIS ANDREW NExecutive Chairman
|
SaleCommon Stock | 9,664 | $70.10 | $677,464.76 |
DisclosureSEC source: 0001225208-17-018911 · doc4.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,936.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $71.10 to $71.11. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 21:44 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionCommon Stock | 9,664 | $38.62 | $373,223.68 |
DisclosureSEC source: 0001225208-17-018911 · doc4.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659,600.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2017 Filed Dec 13, 2017 21:30 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
GiftCommon Stock | 1,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018598 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,543.7416 Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 20:15 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 78,582 | $38.62 Strike: $38.62 | $3,034,836.84 |
DisclosureSEC source: 0001225208-17-018728 · doc4.xml · derivative · entry 6 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,663 Underlying: Common Stock · 78,582 shares Expires 2018-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F4 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2009. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 20:15 UTC |
LIVERIS ANDREW NExecutive Chairman
|
SaleCommon Stock | 78,582 | $71.00 | $5,579,604.90 |
DisclosureSEC source: 0001225208-17-018728 · doc4.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,936.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $71.00 to $71.03. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 20:15 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionCommon Stock | 78,582 | $38.62 | $3,034,836.84 |
DisclosureSEC source: 0001225208-17-018728 · doc4.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 728,518.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2017 Filed Dec 15, 2017 11:07 UTC |
Ungerleider Howard IChief Financial Officer
|
GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018709 · doc4.xml · nonDerivative · entry 1 Ungerleider Howard I · CIK 0001514396 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 104,387.9183 Read SEC document |
| December 08, 2017 Filed Dec 11, 2017 21:38 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 24,811 | $38.62 Strike: $38.62 | $958,200.82 |
DisclosureSEC source: 0001225208-17-018485 · doc4.xml · derivative · entry 9 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,245 Underlying: Common Stock · 24,811 shares Expires 2018-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F5 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2009. Read SEC document |
| December 08, 2017 Filed Dec 11, 2017 21:38 UTC |
LIVERIS ANDREW NExecutive Chairman
|
SaleCommon Stock | 24,811 | $71.50 | $1,774,095.67 |
DisclosureSEC source: 0001225208-17-018485 · doc4.xml · nonDerivative · entry 4 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,936.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · price: The price represents the weighted average sale price. All sales occurred at a range of $71.50 to $71.52. Read SEC document |
| December 08, 2017 Filed Dec 11, 2017 21:38 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionCommon Stock | 24,811 | $38.62 | $958,200.82 |
DisclosureSEC source: 0001225208-17-018485 · doc4.xml · nonDerivative · entry 3 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 674,747.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 21:38 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 4,912 | $38.62 Strike: $38.62 | $189,701.44 |
DisclosureSEC source: 0001225208-17-018485 · doc4.xml · derivative · entry 8 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,056 Underlying: Common Stock · 4,912 shares Expires 2018-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F5 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2009. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 21:38 UTC |
LIVERIS ANDREW NExecutive Chairman
|
SaleCommon Stock | 4,912 | $71.50 | $351,208.00 |
DisclosureSEC source: 0001225208-17-018485 · doc4.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,936.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: All sales occurred at a price of $71.50. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 21:38 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionCommon Stock | 4,912 | $38.62 | $189,701.44 |
DisclosureSEC source: 0001225208-17-018485 · doc4.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 654,848.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2017 Filed Dec 5, 2017 22:13 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,590 | $38.62 Strike: $38.62 | $215,885.80 |
DisclosureSEC source: 0001225208-17-018262 · doc4.xml · derivative · entry 12 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,968 Underlying: Common Stock · 5,590 shares Expires 2018-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F7 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2009. Read SEC document |
| December 05, 2017 Filed Dec 5, 2017 22:13 UTC |
LIVERIS ANDREW NExecutive Chairman
|
GiftCommon Stock | 138,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018262 · doc4.xml · nonDerivative · entry 7 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 682,824.5 F5 · shares: These shares were gifted to a charitable foundation that is controlled by the reporting person and his spouse. Read SEC document |
| December 05, 2017 Filed Dec 5, 2017 22:13 UTC |
LIVERIS ANDREW NExecutive Chairman
|
SaleCommon Stock | 5,590 | $72.89 | $407,428.27 |
DisclosureSEC source: 0001225208-17-018262 · doc4.xml · nonDerivative · entry 6 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,936.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F4 · price: The price represents the weighted average sale price. All sales occurred at a range of $72.85 to $72.90. Read SEC document |
| December 05, 2017 Filed Dec 5, 2017 22:13 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionCommon Stock | 5,590 | $38.62 | $215,885.80 |
DisclosureSEC source: 0001225208-17-018262 · doc4.xml · nonDerivative · entry 5 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,526.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2017 Filed Dec 5, 2017 22:13 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 31,812 | $38.62 Strike: $38.62 | $1,228,579.44 |
DisclosureSEC source: 0001225208-17-018262 · doc4.xml · derivative · entry 11 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,558 Underlying: Common Stock · 31,812 shares Expires 2018-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F7 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2009. Read SEC document |
| December 04, 2017 Filed Dec 5, 2017 22:13 UTC |
LIVERIS ANDREW NExecutive Chairman
|
SaleCommon Stock | 31,812 | $72.89 | $2,318,649.43 |
DisclosureSEC source: 0001225208-17-018262 · doc4.xml · nonDerivative · entry 4 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,936.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · price: The price represents the weighted average sale price. All sales occurred at a range of $72.85 to $72.94. Read SEC document |
| December 04, 2017 Filed Dec 5, 2017 22:13 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionCommon Stock | 31,812 | $38.62 | $1,228,579.44 |
DisclosureSEC source: 0001225208-17-018262 · doc4.xml · nonDerivative · entry 3 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 681,748.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:13 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 150,000 | $38.62 Strike: $38.62 | $5,793,000.00 |
DisclosureSEC source: 0001225208-17-018262 · doc4.xml · derivative · entry 10 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,370 Underlying: Common Stock · 150,000 shares Expires 2018-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F7 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2009. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:13 UTC |
LIVERIS ANDREW NExecutive Chairman
|
SaleCommon Stock | 150,000 | $72.06 | $10,809,720.00 |
DisclosureSEC source: 0001225208-17-018262 · doc4.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,936.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $72.00 to $72.35. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:13 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionCommon Stock | 150,000 | $38.62 | $5,793,000.00 |
DisclosureSEC source: 0001225208-17-018262 · doc4.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 799,936.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2017 Filed Dec 4, 2017 17:10 UTC |
JULIBER LOIS DDirector
|
GrantCommon Stock | 243.1907 | $71.96 | $17,500.00 |
DisclosureSEC source: 0001127294-17-000010 · edgar.xml · nonDerivative · entry 1 JULIBER LOIS D · CIK 0001127294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,334.4328 F1 · balance_after: Includes direct ownership, unvested RSUs and vested deferred stock units. Read SEC document |
| November 30, 2017 Filed Dec 4, 2017 22:10 UTC |
CUTLER ALEXANDER MDirector
|
GrantCommon Stock | 689.0403 | $71.96 | $49,583.34 |
DisclosureSEC source: 0001188585-17-000010 · edgar.xml · nonDerivative · entry 1 CUTLER ALEXANDER M · CIK 0001188585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,154.0186 F1 · balance_after: Includes direct ownership, unvested RSUs and vested deferred stock units. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 13:44 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 100,551 | $38.62 Strike: $38.62 | $3,883,279.62 |
DisclosureSEC source: 0001225208-17-017923 · doc4.xml · derivative · entry 6 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,370 Underlying: Common Stock · 100,551 shares Expires 2018-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F4 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2009. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 13:44 UTC |
LIVERIS ANDREW NExecutive Chairman
|
SaleCommon Stock | 100,551 | $71.54 | $7,193,780.52 |
DisclosureSEC source: 0001225208-17-017923 · doc4.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,936.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $71.5000 to $71.7015. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 13:44 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionCommon Stock | 100,551 | $38.62 | $3,883,279.62 |
DisclosureSEC source: 0001225208-17-017923 · doc4.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,487.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 13:44 UTC |
Fitterling James RChief Operating Officer-MatCo
|
GiftCommon Stock | 10,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-017922 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,004.949 Read SEC document |
| November 21, 2017 Filed Nov 24, 2017 13:31 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 49,449 | $38.62 Strike: $38.62 | $1,909,720.38 |
DisclosureSEC source: 0001225208-17-017658 · doc4.xml · derivative · entry 6 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569,921 Underlying: Common Stock · 49,449 shares Expires 2018-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F4 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2009. Read SEC document |
| November 21, 2017 Filed Nov 24, 2017 13:31 UTC |
LIVERIS ANDREW NExecutive Chairman
|
SaleCommon Stock | 49,449 | $71.63 | $3,542,185.16 |
DisclosureSEC source: 0001225208-17-017658 · doc4.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,936.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $71.60 to $71.72. Read SEC document |
| November 21, 2017 Filed Nov 24, 2017 13:31 UTC |
LIVERIS ANDREW NExecutive Chairman
|
Exercise / conversionCommon Stock | 49,449 | $38.62 | $1,909,720.38 |
DisclosureSEC source: 0001225208-17-017658 · doc4.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 699,385.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2017 Filed Nov 24, 2017 13:30 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
SaleCommon Stock | 40,528 | $71.51 | $2,898,027.59 |
DisclosureSEC source: 0001225208-17-017657 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,390.7416 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $71.49 to $71.545. Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:13 UTC |
Collins James C. Jr.Chief Operating Officer
|
SaleCommon Stock | 15,000 | $71.11 | $1,066,635.00 |
DisclosureSEC source: 0001625045-17-000012 · edgar.xml · nonDerivative · entry 1 Collins James C. Jr. · CIK 0001625045 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,899.4747 F1 · price: Weighted average sales price of $71.1090. Trades ranged from $71.0523 to $71.1401. Upon request, the reporting person will provide to the Commission, the issuer and any stockholder full information regarding the number of shares that were sold at each separate price. F2 · balance_after: Includes direct ownership and unvested restricted stock units. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 21:28 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
SaleCommon Stock | 23,778 | $70.70 | $1,681,213.98 |
DisclosureSEC source: 0001225208-17-017520 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,918.7416 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $70.66 to $70.725. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:15 UTC |
Fitterling James RChief Operating Officer-MatCo
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 22,170 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0001225208-17-017211 · doc4.xml · derivative · entry 10 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,710 Underlying: Common Stock · 22,170 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted under The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F5 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2014. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:15 UTC |
Fitterling James RChief Operating Officer-MatCo
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 61,830 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001225208-17-017211 · doc4.xml · derivative · entry 9 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,830 shares Expires 2022-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F3 · derivative.exercise_date: The options vested in three annual installments beginning on February 10, 2013. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:15 UTC |
Fitterling James RChief Operating Officer-MatCo
|
Tax withholdingCommon Stock | 29,566 | $71.11 | $2,102,290.43 |
DisclosureSEC source: 0001225208-17-017211 · doc4.xml · nonDerivative · entry 6 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,846.949 Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:15 UTC |
Fitterling James RChief Operating Officer-MatCo
|
Tax withholdingCommon Stock | 14,907 | $71.11 | $1,059,962.24 |
DisclosureSEC source: 0001225208-17-017211 · doc4.xml · nonDerivative · entry 5 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,412.949 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:15 UTC |
Fitterling James RChief Operating Officer-MatCo
|
Tax withholdingCommon Stock | 10,028 | $71.11 | $713,040.94 |
DisclosureSEC source: 0001225208-17-017211 · doc4.xml · nonDerivative · entry 4 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,319.949 Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:15 UTC |
Fitterling James RChief Operating Officer-MatCo
|
Tax withholdingCommon Stock | 5,610 | $71.11 | $398,899.05 |
DisclosureSEC source: 0001225208-17-017211 · doc4.xml · nonDerivative · entry 3 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,347.949 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:15 UTC |
Fitterling James RChief Operating Officer-MatCo
|
Exercise / conversionCommon Stock | 22,170 | $32.16 | $712,987.20 |
DisclosureSEC source: 0001225208-17-017211 · doc4.xml · nonDerivative · entry 2 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,957.949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:15 UTC |
Fitterling James RChief Operating Officer-MatCo
|
Exercise / conversionCommon Stock | 61,830 | $34.00 | $2,102,220.00 |
DisclosureSEC source: 0001225208-17-017211 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,787.949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:28 UTC |
Desmond Jeanmarie F.Co-Controller
|
Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 6,708 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001713192-17-000004 · edgar.xml · derivative · entry 4 Desmond Jeanmarie F. · CIK 0001713192 · Co-Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,708 shares Expires 2021-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options become exercisable in three equal annual installments beginning on the first anniversary of the grant. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:28 UTC |
Desmond Jeanmarie F.Co-Controller
|
SaleCommon Stock | 6,708 | $71.01 | $476,349.17 |
DisclosureSEC source: 0001713192-17-000004 · edgar.xml · nonDerivative · entry 2 Desmond Jeanmarie F. · CIK 0001713192 · Co-Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,440.2611 F1 · balance_after: Includes direct ownership, unvested RSUs and vested deferred stock units. Amount previously reported on Form 4 filed October 3, 2017, overstated dividend equivalent units by 15.3965 shares. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:28 UTC |
Desmond Jeanmarie F.Co-Controller
|
Exercise / conversionCommon Stock | 6,708 | $46.54 | $312,190.32 |
DisclosureSEC source: 0001713192-17-000004 · edgar.xml · nonDerivative · entry 1 Desmond Jeanmarie F. · CIK 0001713192 · Co-Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,148.2611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes direct ownership, unvested RSUs and vested deferred stock units. Amount previously reported on Form 4 filed October 3, 2017, overstated dividend equivalent units by 15.3965 shares. Read SEC document |
| November 07, 2017 Filed Nov 9, 2017 21:49 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
SaleCommon Stock | 78,895 | $71.00 | $5,601,545.00 |
DisclosureSEC source: 0001225208-17-017151 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,696.7416 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $70.89 to $71.13. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 16:53 UTC |
THOMAS LEE MDirector
|
GrantCommon Stock | 190 | $0.00 | $0.00 |
DisclosureSEC source: 0001666700-17-000028 · edgar.xml · nonDerivative · entry 1 THOMAS LEE M · CIK 0001090724 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,703.1758 F1 · balance_after: Includes direct ownership and unvested restricted stock units. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 16:52 UTC |
JULIBER LOIS DDirector
|
GrantCommon Stock | 190 | $0.00 | $0.00 |
DisclosureSEC source: 0001127294-17-000009 · edgar.xml · nonDerivative · entry 1 JULIBER LOIS D · CIK 0001127294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,091.2421 F1 · balance_after: Includes direct ownership, unvested restricted stock units and vested deferred stock units. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:55 UTC |
BREEN EDWARD DDirector · Chief Executive Officer
|
GrantStock Options (Right to Buy) NQOs · Derivative | 107,672 | $0.00 Strike: $70.24 | $0.00 |
DisclosureSEC source: 0001666700-17-000030 · edgar.xml · derivative · entry 1 BREEN EDWARD D · CIK 0001223619 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,672 Underlying: Common Stock · 107,672 shares Expires 2027-11-05 F1 · derivative.exercise_date: Options become exercisable in three substantially equal installments beginning on the first anniversary of the grant, option shares used to satisfy withholding taxes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.